BIOS Capital Management
Latest statistics and disclosures from BIOS Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACTU, IRD, CGTX, RNTX, LTRN, and represent 99.73% of BIOS Capital Management's stock portfolio.
- Added to shares of these 1 stock: RNTX.
- Reduced shares in these 2 stocks: LTRN, INAB.
- BIOS Capital Management was a net seller of stock by $-1.6M.
- BIOS Capital Management has $42M in assets under management (AUM), dropping by -21.18%.
- Central Index Key (CIK): 0001813845
Tip: Access up to 7 years of quarterly data
Positions held by BIOS Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for BIOS Capital Management
BIOS Capital Management holds 6 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Actuate Therapeutics (ACTU) | 36.9 | $15M | 10M | 1.53 |
|
|
| Ocuphire Pharma (IRD) | 36.3 | $15M | 3.7M | 4.11 |
|
|
| Cognition Therapeutics (CGTX) | 16.6 | $6.9M | 6.0M | 1.15 |
|
|
| Rein Therapeutics Com New (RNTX) | 7.4 | $3.1M | +50% | 3.0M | 1.04 |
|
| Lantern Pharma (LTRN) | 2.5 | $1.0M | -71% | 249k | 4.17 |
|
| In8bio Com New (INAB) | 0.3 | $114k | -51% | 81k | 1.41 |
|
Past Filings by BIOS Capital Management
SEC 13F filings are viewable for BIOS Capital Management going back to 2024
- BIOS Capital Management 2026 Q2 filed Aug. 14, 2026
- BIOS Capital Management 2026 Q1 filed May 13, 2026
- BIOS Capital Management 2025 Q4 filed Feb. 13, 2026
- BIOS Capital Management 2025 Q3 filed Nov. 12, 2025
- BIOS Capital Management 2025 Q2 filed Aug. 12, 2025
- BIOS Capital Management 2025 Q1 filed May 14, 2025
- BIOS Capital Management 2024 Q4 restated filed Feb. 18, 2025
- BIOS Capital Management 2024 Q4 filed Feb. 10, 2025